Evonetix
Web Hosting & VPS
Facts
as of Nov 19, 2026- Website
- evonetix.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Financials
Funding rounds, investors and revenue on record.
$24MTotal raised
Venture - Series UnknownLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
$24M
Sources: funding announcements, grant and company registers
Money
Evonetix has $24M paid in by investors, lenders and donors.
$24MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
$24MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Milestones
Feb 7, 2023
Raised a round Venture round $24M · NewsMedical
Jun 13, 2022
Each milestone is dated by its source: registers, filings, the press
Newsroom
Sep 292026
News · pharmtech.com
The partners will collaborate on developing scale-up chip-based technology to enable commercial-scale production of a third-generation DNA synthesis platform.
Sep 292026
News · pharmtech.com
Evonetix Receives Patent for Thermally-Controlled DNA Synthesis Technology Pharmaceutical Technology
Evonetix's thermally controlled DNA synthesis technology is designed to enable highly parallel DNA synthesis in a benchtop platform.
Sources: the outlets named on each headline, each story once
